Advertisement
News
Subscribe to MDT Magazine News

Tygacil (tigecycline): Label Change - Increased Mortality Risk

September 1, 2010 11:30 am | by U.S. Food & Drug Administration | Comments

Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.

TOPICS:

Omnicare buys Continuing Care Rx

September 1, 2010 9:45 am | by The Associated Press | Comments

Omnicare Inc., which dispenses drugs to nursing homes and long-term care facilities, said Wednesday it bought privately held Continuing Care Rx for an undisclosed amount.Continuing Care, based in Harrisburg, Pa., provides pharmacy services to residents of long-term care and other facilities in...

LHC Group acquires home health agency

September 1, 2010 8:45 am | by The Associated Press | Comments

Home health provider LHC Group Inc. says it has acquired the assets of a home health agency in Harrodsburg, Ky.Terms of the deal with James B. Haggin Memorial Hospital were not revealed. Lafayette-based LHC Group will take over the operations of Haggin Home Health. The agency will be renamed...

Advertisement

Results From Investigator-Sponsored Trials Presented at SSIEM Conference

September 1, 2010 7:31 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., Sept. 1 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism...

TOPICS:

FoldRx to be acquired by Pfizer

September 1, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge small molecule therapeutics firm FoldRx Pharmaceuticals Inc. is going to be acquired by pharmaceutical giant Pfizer Inc. as part of the latter company’s overall strategy to increase its pipeline of drugs to treat rare diseases.

TOPICS:

<i>Tech across New England: </i>ProThera Biologics takes holistic approach to treating inflammation

September 1, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. ProThera Biologics develops technology centered on a protein in the blood that regulates the immune system and is the key to controlling sepsis...

TOPICS:

PerkinElmer pulls in $500M from sales of IDS unit

September 1, 2010 6:32 am | by Mass High Tech: The Journal of New England Technology | Comments

In its latest move of adding or subtracting business lines, PerkinElmer Inc. reports it has agreed to sell its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III LP, a New York-based private equity firm, for approximately $500 million in cash.

TOPICS:

Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & Sullivan

September 1, 2010 4:33 am | by Bio-Medicine.Org | Comments

LONDON, Sept. 1 /- The pharmacy automation systems market in Europe is experiencing a tremendous growth spurt. Until recently, most pharmacies have been either without automation or have employed very basic automation systems. In response, the adoption rate of automation systems across...

TOPICS:
Advertisement

St. Jude Children's Research Hospital Doctors and Scientists Team up to Fight Childhood Cancer

September 1, 2010 4:32 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., Sept. 1 /PRNewswire-USNewswire/ -- Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading...

TOPICS:

Covidien Announces Investor Meeting Agenda

September 1, 2010 3:32 am | by Covidien | Comments

DUBLIN, Sep 01, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 15, 2010. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY....

TOPICS:

JDSU expands into solar and gaming markets

August 31, 2010 10:33 pm | by I-Micronews | Comments

The diversified optical technologies company is expanding production of components used in new "gesture recognition" games consoles.

SCHOTT Solar and Solland Solar sign partnership agreement

August 31, 2010 10:33 pm | by I-Micronews | Comments

SCHOTT Solar and Solland Solar signed a partnership agreement that comprises technology license agreements, joint R&D efforts and joint production for back-contacted solar modules.

New device packs power to analyze genes, proteins at patients' bedside

August 31, 2010 10:32 pm | by I-Micronews | Comments

University of Florida researchers have helped to develop a device that quickly identifies genes and proteins in body fluids, a technique that could make a vital difference to the trauma patients doctors treat.

<i>Tech across New England: </i>Stromatec devices made to treat connective tissue problems

August 31, 2010 10:32 pm | by Mass High Tech: The Journal of New England Technology | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. Stromatec specializes in medical devices that could help reduce health care costs by preventing unnecessary MRIs and even unnecessary surgery, by...

TOPICS:

<i>Tech across New England: </i>EpiVax poised to lead vaccine developments

August 31, 2010 9:33 pm | by Mass High Tech: The Journal of New England Technology | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. EpiVax applies its tools to screening proteins for unwanted immune responses and using these tools to design and deimmunize protein therapeutics and vaccines.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading